News & Updates

Show Multimedia Only

Use of rhGM-CSF promotes wound healing via macrophage immunomodulation

19 Mar 2026

Topical administration of recombinant human granulocyte macrophage–colony stimulating factor (rhGM-CSF) helps induce healing of diabetic and nondiabetic wounds, suggests a study.

Use of rhGM-CSF promotes wound healing via macrophage immunomodulation

19 Mar 2026

Phase III PHILA final analysis: Pyrotinib + trastuzumab and docetaxel prolongs PFS & OS in HER2+ Tx-naïve mBC

19 Mar 2026 by

Extended analysis of the phase III PHILA trial confirms superiority of pyrotinib in combination with trastuzumab and docetaxel (TD) vs placebo in combination with TD in sustaining longer progression-free survival (PFS) and improving overall survival (OS) in treatment-naïve patients with HER2-positive (HER2+) metastatic breast cancer (mBC).

Phase III PHILA final analysis: Pyrotinib + trastuzumab and docetaxel prolongs PFS & OS in HER2+ Tx-naïve mBC

19 Mar 2026

OASIS in nulliparous and multiparous Asian women: When is episiotomy appropriate?

19 Mar 2026 by

A retrospective study from the Chinese University of Hong Kong (CUHK) finds episiotomy to be protective against obstetric anal sphincter injury (OASIS) among nulliparous Asian women with singleton normal vaginal or instrumental delivery as well as multiparous women undergoing instrumental delivery, but not multiparous women having normal vaginal delivery.

OASIS in nulliparous and multiparous Asian women: When is episiotomy appropriate?

19 Mar 2026

Medically supervised ketogenic diet shows trends of improved PFS & OS in pancreatic cancer patients on chemo

19 Mar 2026 by

A randomized phase II trial reports feasibility of and trends towards improved progression-free survival (PFS) and overall survival (OS) with medically supervised ketogenic diet (MSKD) in treatment-naïve patients with metastatic pancreatic ductal adenocarcinoma (PDAC) receiving gemcitabine, nab‐paclitaxel and cisplatin chemotherapy.

Medically supervised ketogenic diet shows trends of improved PFS & OS in pancreatic cancer patients on chemo

19 Mar 2026

Sivelestat helps mitigate ARDS risk in cardiovascular procedures

19 Mar 2026

Treatment with sivelestat in patients undergoing cardiovascular procedures appears to lower the incidence of acute respiratory distress syndrome (ARDS) and all-cause mortality, as reported in a study.

Sivelestat helps mitigate ARDS risk in cardiovascular procedures

19 Mar 2026

Original New Drug Application Approvals by US FDA (16-28 February 2026)

19 Mar 2026

New drug applications approved by US FDA as of 16-28 February 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-28 February 2026)

19 Mar 2026

Original New Drug Application Approvals by US FDA (1-15 March 2026)

19 Mar 2026

New drug applications approved by US FDA as of 1-15 March 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 March 2026)

19 Mar 2026

Bladder-sparing regimen for MIBC shows promising antitumour activity

18 Mar 2026 by

In the treatment of patients with muscle-invasive bladder cancer (MIBC), a perioperative regimen of the antibody–drug conjugate sacituzumab govitecan plus pembrolizumab yields a promising clinical complete response rate without eliciting grade ≥4 adverse events (AEs), allowing bladder preservation without further therapy in some patients, according to the phase II SURE-02 trial.

Bladder-sparing regimen for MIBC shows promising antitumour activity

18 Mar 2026

Smartwatch enhances AF detection in patients at risk of stroke

18 Mar 2026

The use of a smartwatch-based atrial fibrillation (AF) screening results in improved detection rates of new-onset AF relative to standard care in patients at increased risk of stroke, reports a study.

Smartwatch enhances AF detection in patients at risk of stroke

18 Mar 2026

Pemivibart prevents COVID-19 in people with advanced HIV

18 Mar 2026 by

Individuals living with advanced HIV infection who received pemivibart demonstrate good tolerability, with no cases of RT-PCR-confirmed symptomatic COVID-19 reported through month 6, as shown by the results of a subgroup analysis of the CANOPY study.

Pemivibart prevents COVID-19 in people with advanced HIV

18 Mar 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Use of rhGM-CSF promotes wound healing via macrophage immunomodulation

Use of rhGM-CSF promotes wound healing via macrophage immunomodulation

Phase III PHILA final analysis: Pyrotinib + trastuzumab and docetaxel prolongs PFS & OS in HER2+ Tx-naïve mBC

Phase III PHILA final analysis: Pyrotinib + trastuzumab and docetaxel prolongs PFS & OS in HER2+ Tx-naïve mBC

OASIS in nulliparous and multiparous Asian women: When is episiotomy appropriate?

OASIS in nulliparous and multiparous Asian women: When is episiotomy appropriate?

Medically supervised ketogenic diet shows trends of improved PFS & OS in pancreatic cancer patients on chemo

Medically supervised ketogenic diet shows trends of improved PFS & OS in pancreatic cancer patients on chemo

Sivelestat helps mitigate ARDS risk in cardiovascular procedures

Sivelestat helps mitigate ARDS risk in cardiovascular procedures

Original New Drug Application Approvals by US FDA (16-28 February 2026)

Original New Drug Application Approvals by US FDA (16-28 February 2026)

Original New Drug Application Approvals by US FDA (1-15 March 2026)

Original New Drug Application Approvals by US FDA (1-15 March 2026)

Bladder-sparing regimen for MIBC shows promising antitumour activity

Bladder-sparing regimen for MIBC shows promising antitumour activity

Smartwatch enhances AF detection in patients at risk of stroke

Smartwatch enhances AF detection in patients at risk of stroke

Pemivibart prevents COVID-19 in people with advanced HIV

Pemivibart prevents COVID-19 in people with advanced HIV